Upload
wing-richards
View
49
Download
0
Embed Size (px)
DESCRIPTION
Heart Disease in Pregnancy: Validity of CARPREG Score in local population Eliza M.N (1), Quek Y.S. (1), Woon S.Y. (1), Ravichandan N. (2), Ravichandran J. (1) 1. Hospital Sultanah Aminah Johor Bahru, Malaysia 2. Singapore General Hospital. OPTIONAL LOGO HERE. OPTIONAL LOGO HERE. Objectives. - PowerPoint PPT Presentation
Citation preview
TEMPLATE DESIGN © 2008
www.PosterPresentations.com
Heart Disease in Pregnancy: Validity of CARPREG Score in local populationEliza M.N (1), Quek Y.S. (1), Woon S.Y. (1), Ravichandan N. (2), Ravichandran J. (1)
1. Hospital Sultanah Aminah Johor Bahru, Malaysia 2. Singapore General Hospital
Objectives Results Conclusions
References
Report of Confidential enquiry into maternal deaths in 1997-
2000 showed that the commonest cause of death is due to
medical disorders in pregnancy which consists of 20.6%.
Heart disease in pregnancy is the leading cause of death due
to medical disorders especially due to valvular lesions and
followed by congenital heart disease. There are four
predictors used to determine mortality associated with heart
disease, called CARPREG score. They are prior cardiac
event ( heart failure/ stroke ), baseline NYHA >II, left heart
obstruction ( mitral area <2cm, aortic area < 1.5cm or peak
left ventricular outflow gradient > 30mmhg by ECHO ) and
reduced systemic ventricular ejection fraction ( < 40% ) .
This study is to asses the validity of a risk score index
(CARPREG) in predicting maternal and perinatal outcome in
pregnant patients with heart diseases in our population.
The main finding of this study is that pregnant women with
various forms of heart disease experience an overall low risk of
cardiac complications if their CARPREG score is low. This
cardiac event observed was lower than most studies done.
In our study we categorized patients according to the
previous validated carpreg score, however some limitations of
the carpreg score must be recognized. Lesion specific
predictors need to be incorporated in the scoring and prior
cardiac event such as arrhythmia would be too vague as the
outcome for treated and treated event was not mentioned
specifically. As for NYHA class, it would patient and the
doctors own evaluation which may sometimes be inaccurate.
Several limitations of our study also needs to be considered
as some patients who were discharged home may have had a
cardiac event which have been missed.
In conclusion, the cardiac events observed in our study was
relatively lower compared to the standard outcome in the
CARPREG scoring system, thus a different method or scoring
system is required in our local setting. More research and
bigger studies need to be done to assess the validity of this
scoring system and other scoring system as well .
Results
OPTIONALLOGO HERE
OPTIONALLOGO HERE
Methods
A prospective observational study in pregnant women
diagnosed with heart disease for 1 year duration involving 150
patients managed by combine obstetrician and cardiologist.
Patients went through CARPREG risk scoring and their
cardiac events were observed. The rate of cardiac
complications according to the CARPREG score for a patient
with a score of 0,1 and >1 was 5%, 27% and 75% respectively.
The demographic data for all these patients were also
observed.
Majority of our patients were grouped in Carpreg 0 (Figure 1).
Among 150 cases recruited, 61 of them were congenital heart disease
with 89 acquired heart disease (Table 1). Occurrence of cardiac
events in relation to carpreg score category were as in Table 2.
1. Jastrow N, Meyer P, Kahiry P, et al. Prediction of complications in pregnant women with cardiac diseases referred to a tertiary center. Int. J Cardiol 2011;151:209-213.
2. Ruth C., Swan L., Steera PJ. Cardiac disease in pregnancy. Curr Opinion Obstet Gynecol 2009;21:508-513.
3. Willem D., Eric B., Balci A., et al. Predictors of pregnancy complications in women with congenital heart disease. European Heart J 2010;31:2124-2132.
4. Samuel CS, Sermer M, Colman JM, et al. Prospective Multicenter Study of Pregnancy Outcomes in Women with Heart Disease. Am Heart Assoc Circulation 2001; 104:515-521.
5. Paul K., Ouyang DW., Fernandes SM., et al. Pregnancy Outcomes in Women with Congenital Heart Disease. Am J Heart Assoc 2006; 113:517-524.
Table 1. Carpreg Score in different cardiac disease
Carpreg Score Congenital
(n = 61)
Acquired
(n = 89)
Total
(n = 150)
0 53 (86.9) 60 (67.4) 113 (75.3)
1 4 (6.6) 20 (22.5) 24 (16)
2 4 (6.6) 9 (10.1) 13 (8.7)
Data presented as n (%)
Table 2. Carpreg Score and Cardiac Events
Data presented as n (%)
Carpreg
Score 0
Carpreg
Score 1
Carpreg
Score 2
Total
Presence of Cardiac Event
Yes 1 (0.9) 3 (12.5) 4 (30.8) 8 (5.3)
No 112 (99.1) 21 (87.5) 9 (69.2) 142 (94.7)
Onset of Cardiac Event
Antepartum 1 (100) 1 (33.3) 3 (75) 5 (62.5)
Postpartum 0 (0) 2 (66.7) 1 (25) 3 (37.5)
Maternal mortality 0 (0) 1 (4.2) 1 (7.7) 2 (1.3)
Ocurrence of cardiac events were further subcategorized
into congenital or acquired heart disease in relation to
carpreg score category (Table 3 & 4).
Table 3. Cardiac Events in Acquired Heart Disease
Data presented as n (%)
Carpreg
Score 0
Carpreg
Score 1
Carpreg
Score 2
Total
Presence of Cardiac Event
Yes 1 (1.7) 3 (15.0) 1 (11.1) 5 (5.6)
No 59 (98.3) 17 (85.0) 8 (88.9) 84 (94.4)
Onset of Cardiac Event
Antepartum 1 (100) 1 (33.3) 1 (100) 3 (60)
Postpartum 0 (0) 2 (66.7) 0 (0) 2 (40)
Type of Cardiac Event
Heart Failure 1 (1.1) 2 (2.2) 1 (1.1) 4 (5.4)
Maternal Mortality 0 (0) 1 (1.1) 0 (0) 1 (1.1)
Table 4. Cardiac Events in Congenital Heart Disease
Carpreg
Score 0
Carpreg
Score 1
Carpreg
Score 2
Total
Presence of Cardiac Event
Yes 0 (0) 0 (0) 3 (75) 3 (4.9)
No 53 (100) 4 (100) 1 (25) 58 (95.1)
Onset of Cardiac Event
Antepartum NA* NA* 2 (66.7) 2 (66.7)
Postpartum NA* NA* 1 (33.3) 1 (33.3)
Type of Cardiac Event
Heart Failure NA* NA* 2 (66.7) 2 (66.7)
Maternal Mortality NA* NA* 1 (33.3) 1 (33.3)Data presented as n (%). * Not applicable
All these cardiac event was heart failure , however there
was one maternal death and this occurred postpartum in the
CARPREG 1 group. The patient was a 33 year old
primigravida who was diagnosed to have chronic rheumatic
heart disease and had severe aortic stenosis. She was
admitted from 30 weeks onwards and was on beta blockers,
aspirin and metoprolol. The pregnancy ended up with an
IUD and was delivered via caeserian section. She
succumbed to the illness during postpartum.